Form 4: Quest Diagnostics SVP Sells 403 Shares of Common Stock
SEC Form 4
Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, sold 403 shares of common stock at a price of $164.3031 on February 5, 2025.
Summary
- Mark E. Delaney, a Senior Vice President and Chief Commercial Officer at Quest Diagnostics Inc., sold 403 shares of the company's common stock on February 5, 2025.
- The sale price was $164.3031 per share.
- Following the transaction, Delaney directly owns 4,624 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of an insider transaction. The sale itself doesn't necessarily indicate a positive or negative outlook.
Industry Context
This is a routine disclosure of an insider transaction. It's important to monitor such filings to understand management's perspective on the company's stock.
Stakeholder Impact
- The sale of shares by a company executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction.
Key Dates
| Date | Description |
|---|---|
| 02/05/2025 | Date of transaction: Mark E. Delaney sold 403 shares of Quest Diagnostics common stock. |
| 02/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.